Can a pill and brain zaps help you quit smoking for good?

NCT ID NCT07145866

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests whether adding accelerated transcranial magnetic stimulation (aTMS) to the standard smoking-cessation drug varenicline helps adults quit nicotine products like cigarettes and vapes. Thirty participants will take varenicline daily for 12 weeks and receive either real or sham aTMS over 5 consecutive days. Researchers will track abstinence through saliva tests and brain scans to see if the combination reduces cravings and improves quit rates.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
varenicline and transcranial magnetic stimulation (TMS)
What this could lead to
If it works, this could point toward a more effective way to help people quit smoking or vaping by combining medication with brain stimulation.
What could go wrong
This is a small early-phase trial with only 30 people, so results may not apply to everyone. The TMS is given over just 5 days, and the sham group may also improve, making it hard to see a clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NICOTINE DEPENDENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive nicotine dependence Smoking Smoking Cessation Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.